2.595
前日終値:
$1.92
開ける:
$2.44
24時間の取引高:
20.13M
Relative Volume:
14.27
時価総額:
$410.96M
収益:
$400.57M
当期純損益:
$9.21M
株価収益率:
64.88
EPS:
0.04
ネットキャッシュフロー:
$146.36M
1週間 パフォーマンス:
+39.52%
1か月 パフォーマンス:
+63.72%
6か月 パフォーマンス:
+265.91%
1年 パフォーマンス:
-47.68%
Ironwood Pharmaceuticals Inc Stock (IRWD) Company Profile
名前
Ironwood Pharmaceuticals Inc
セクター
電話
617-621-7722
住所
100 SUMMER STREET, SUITE 2300, BOSTON, MA
IRWD を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
IRWD
Ironwood Pharmaceuticals Inc
|
2.53 | 311.87M | 400.57M | 9.21M | 146.36M | 0.04 |
|
ZTS
Zoetis Inc
|
119.79 | 52.99B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.71 | 43.15B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.57 | 42.12B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
24.26 | 27.50B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
453.93 | 19.33B | 3.08B | 1.24B | 1.07B | 25.61 |
Ironwood Pharmaceuticals Inc Stock (IRWD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-04-15 | ダウングレード | Jefferies | Buy → Hold |
| 2025-04-15 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2025-04-14 | ダウングレード | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2024-09-09 | 開始されました | Leerink Partners | Market Perform |
| 2024-08-08 | ダウングレード | CapitalOne | Overweight → Equal Weight |
| 2024-01-17 | 開始されました | Craig Hallum | Buy |
| 2023-12-14 | 開始されました | Wells Fargo | Overweight |
| 2023-11-09 | 開始されました | Jefferies | Buy |
| 2023-09-28 | 開始されました | JMP Securities | Mkt Outperform |
| 2022-09-02 | 開始されました | CapitalOne | Overweight |
| 2022-04-22 | 開始されました | Piper Sandler | Overweight |
| 2020-09-30 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2020-06-17 | 開始されました | Northland Capital | Outperform |
| 2019-07-10 | 再開されました | Credit Suisse | Neutral |
| 2019-03-27 | アップグレード | Morgan Stanley | Underweight → Equal-Weight |
| 2019-02-25 | アップグレード | H.C. Wainwright | Sell → Neutral |
| 2019-01-24 | アップグレード | JP Morgan | Underweight → Neutral |
| 2018-11-07 | ダウングレード | Credit Suisse | Outperform → Neutral |
| 2018-11-07 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2018-07-23 | 開始されました | H.C. Wainwright | Sell |
| 2018-05-09 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2018-01-05 | ダウングレード | BofA/Merrill | Buy → Underperform |
| 2017-12-06 | ダウングレード | Mizuho | Buy → Neutral |
| 2017-07-21 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2017-05-03 | 開始されました | Wells Fargo | Outperform |
| 2017-04-07 | 繰り返されました | Mizuho | Buy |
| 2017-02-22 | 繰り返されました | Barclays | Equal Weight |
| 2016-11-04 | 繰り返されました | Mizuho | Buy |
| 2016-10-24 | 繰り返されました | Wedbush | Neutral |
| 2016-10-10 | 繰り返されました | Mizuho | Buy |
| 2016-09-27 | 繰り返されました | WallachBeth | Hold |
すべてを表示
Ironwood Pharmaceuticals Inc (IRWD) 最新ニュース
Ironwood Pharmaceuticals (IRWD) Surges 34% on Strong Q3 Results and Raised Guidance - GuruFocus
Ironwood surges after Q3 beat; raised outlook for AbbVie-partnered Linzess - MSN
Ironwood Pharmaceuticals, Inc. Raises Financial Guidance for the Year 2025 - MarketScreener
Ironwood Pharmaceuticals (IRWD) Q3 Earnings and Revenues Surpass Estimates - sharewise.com
Pagaya Technologies Posts Upbeat Q3 Results, Joins Ironwood Pharmaceuticals, TreeHouse Foods And Other Big Stocks Moving Higher On Monday - Benzinga
Will breakout in Ironwood Pharmaceuticals Inc. lead to full recoveryQuarterly Portfolio Review & Weekly Hot Stock Watchlists - newser.com
How Ironwood Pharmaceuticals Inc. stock compares to industry benchmarksVolume Spike & Free Risk Controlled Daily Trade Plans - newser.com
Is Ironwood Pharmaceuticals Inc. stock a dividend growth opportunity2025 Price Action Summary & Weekly Market Pulse Alerts - newser.com
Will earnings trigger a reversal in Ironwood Pharmaceuticals Inc.Gold Moves & Capital Efficiency Focused Strategies - newser.com
Ironwood Pharmaceuticals Posts Strong Growth, Lifts 2025 Forecasts - Finimize
IRWD Increases FY25 EBITDA Outlook and Expands LINZESS Use - GuruFocus
Why Ironwood Pharmaceuticals Inc. (I76) stock could be next leaderJuly 2025 Movers & Comprehensive Market Scan Insights - newser.com
Ironwood Pharmaceuticals (IRWD) Q3 Earnings Beat Expectations; R - GuruFocus
Ironwood: Q3 Earnings Snapshot - News-Times
Ironwood Pharmaceuticals beats Q3 revenue estimates, raises outlook - MarketScreener
Ironwood Pharmaceuticals Reports Strong Third Quarter 2025 Results; Raises Full Year 2025 Financial Guidance - The AI Journal
Ironwood Pharmaceuticals Q3 2025 Financial Results - TradingView
IRONWOOD PHARMACEUTICALS INC SEC 10-Q Report - TradingView
Can Ironwood Pharmaceuticals Inc. stock deliver strong Q4 earningsQuarterly Trade Summary & Real-Time Volume Surge Alerts - newser.com
What’s next for Ironwood Pharmaceuticals Inc. stock priceStop Loss & Daily Chart Pattern Signal Reports - newser.com
Will Ironwood Pharmaceuticals Inc. stock maintain dividend yieldInsider Buying & Daily Stock Trend Watchlist - newser.com
Is it time to cut losses on Ironwood Pharmaceuticals Inc.2025 Volume Leaders & Reliable Entry Point Alerts - newser.com
Will Ironwood Pharmaceuticals Inc. outperform the marketJuly 2025 Earnings & Daily Stock Trend Reports - newser.com
Will Ironwood Pharmaceuticals Inc. stock outperform tech sector in 2025Bear Alert & Risk Adjusted Buy/Sell Alerts - newser.com
Will Ironwood Pharmaceuticals Inc. bounce back from current support2025 Retail Activity & Reliable Trade Execution Plans - newser.com
Live market analysis of Ironwood Pharmaceuticals Inc.Weekly Trend Report & Entry and Exit Point Strategies - newser.com
Can Ironwood Pharmaceuticals Inc. stock continue upward trendJuly 2025 Outlook & Weekly High Return Stock Opportunities - newser.com
Will Ironwood Pharmaceuticals Inc. (I76) stock split increase liquidity2025 Momentum Check & Community Supported Trade Ideas - newser.com
Analysts Offer Insights on Healthcare Companies: Neurogene (NGNE) and Ironwood Pharma (IRWD) - The Globe and Mail
There's No Escaping Ironwood Pharmaceuticals, Inc.'s (NASDAQ:IRWD) Muted Revenues Despite A 39% Share Price Rise - simplywall.st
Price momentum metrics for Ironwood Pharmaceuticals Inc. explained2025 Historical Comparison & Reliable Intraday Trade Plans - newser.com
Momentum Shift: Can Ironwood Pharmaceuticals Inc. (I76) stock attract ESG investmentsWeekly Trade Recap & Safe Capital Growth Tips - Fundação Cultural do Pará
Will Ironwood Pharmaceuticals Inc. stock reach all time highs in 20252025 Trade Ideas & Safe Capital Growth Plans - Fundação Cultural do Pará
Why Ironwood Pharmaceuticals Inc. (I76) stock stays undervalued2025 Market WrapUp & AI Enhanced Trading Signals - Fundação Cultural do Pará
Energy Moves: Why Ironwood Pharmaceuticals Inc. (I76) stock stays undervaluedPortfolio Return Report & Daily Growth Stock Investment Tips - Fundação Cultural do Pará
How Ironwood Pharmaceuticals Inc. (I76) stock trades under stagflationEarnings Miss & Real-Time Volume Analysis Alerts - newser.com
Ironwood Pharmaceuticals Inc (IRWD) 財務データ
収益
当期純利益
現金流量
EPS
Ironwood Pharmaceuticals Inc (IRWD) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| John Minardo | Chief Legal Officer |
Aug 11 '25 |
Sale |
0.84 |
7,754 |
6,513 |
400,378 |
| Martini Gregory S. | Chief Financial Officer |
Aug 11 '25 |
Sale |
0.84 |
1,265 |
1,063 |
182,545 |
| Silver Ronald | Principal Accounting Officer |
Aug 11 '25 |
Sale |
0.84 |
2,846 |
2,391 |
276,809 |
大文字化:
|
ボリューム (24 時間):